Insulin Lispro Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2025-10-24 · last update 2026-09-01
Manufacturers: Eli Lilly and Co.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance. | Posted 09/01/2026 Updated 09/01/2026 Discontinued 09/01/2026 |
| Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 10/24/2025 Updated 10/24/2025 Discontinued 10/24/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)